A citation-based method for searching scientific literature

A E Emery. Neuromuscul Disord 1991
Times Cited: 854







List of co-cited articles
608 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya,[...]. Lancet Neurol 2010
23

Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Jerry R Mendell, Chris Shilling, Nancy D Leslie, Kevin M Flanigan, Roula al-Dahhak, Julie Gastier-Foster, Kelley Kneile, Diane M Dunn, Brett Duval, Alexander Aoyagi,[...]. Ann Neurol 2012
444
18

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
David J Birnkrant, Katharine Bushby, Carla M Bann, Susan D Apkon, Angela Blackwell, David Brumbaugh, Laura E Case, Paula R Clemens, Stasia Hadjiyannakis, Shree Pandya,[...]. Lancet Neurol 2018
338
15

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
David J Birnkrant, Katharine Bushby, Carla M Bann, Benjamin A Alman, Susan D Apkon, Angela Blackwell, Laura E Case, Linda Cripe, Stasia Hadjiyannakis, Aaron K Olson,[...]. Lancet Neurol 2018
288
13

The muscular dystrophies.
Alan E H Emery. Lancet 2002
932
12

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya,[...]. Lancet Neurol 2010
651
9

A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.
Jean K Mah, Lawrence Korngut, Jonathan Dykeman, Lundy Day, Tamara Pringsheim, Nathalie Jette. Neuromuscul Disord 2014
215
9

Dystrophin and mutations: one gene, several proteins, multiple phenotypes.
Francesco Muntoni, Silvia Torelli, Alessandra Ferlini. Lancet Neurol 2003
591
9

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J Roy, Teodora Chamova,[...]. Hum Mutat 2015
293
8

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
906
8

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Jerry R Mendell, Nathalie Goemans, Linda P Lowes, Lindsay N Alfano, Katherine Berry, James Shao, Edward M Kaye, Eugenio Mercuri. Ann Neurol 2016
282
8

Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
B J Petrof, J B Shrager, H H Stedman, A M Kelly, H L Sweeney. Proc Natl Acad Sci U S A 1993
8

X chromosome-linked muscular dystrophy (mdx) in the mouse.
G Bulfield, W G Siller, P A Wight, K J Moore. Proc Natl Acad Sci U S A 1984
7

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine Florence, Michelle Eagle, Eduard Gappmaier, Allan M Glanzman, Robert Spiegel, Jay Barth, Gary Elfring,[...]. Muscle Nerve 2013
156
7



Eteplirsen in the treatment of Duchenne muscular dystrophy.
Kenji Rowel Q Lim, Rika Maruyama, Toshifumi Yokota. Drug Des Devel Ther 2017
186
7

The Dystrophin Complex: Structure, Function, and Implications for Therapy.
Quan Q Gao, Elizabeth M McNally. Compr Physiol 2015
123
7

The importance of genetic diagnosis for Duchenne muscular dystrophy.
Annemieke Aartsma-Rus, Ieke B Ginjaar, Kate Bushby. J Med Genet 2016
136
7

Prevalence of Duchenne and Becker muscular dystrophies in the United States.
Paul A Romitti, Yong Zhu, Soman Puzhankara, Katherine A James, Sarah K Nabukera, Gideon K D Zamba, Emma Ciafaloni, Christopher Cunniff, Charlotte M Druschel, Katherine D Mathews,[...]. Pediatrics 2015
111
7


Pharmacological advances for treatment in Duchenne muscular dystrophy.
Simon Guiraud, Kay E Davies. Curr Opin Pharmacol 2017
80
7

The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.
G Nigro, L I Comi, L Politano, R J Bain. Int J Cardiol 1990
398
6

Therapeutic developments for Duchenne muscular dystrophy.
Ingrid E C Verhaart, Annemieke Aartsma-Rus. Nat Rev Neurol 2019
117
6


The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.
Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine M Florence, Michelle Eagle, Eduard Gappmaier, Allan M Glanzman, Robert Spiegel, Jay Barth, Gary Elfring,[...]. Muscle Nerve 2013
186
5

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
Craig M McDonald, Erik K Henricson, Jay J Han, R Ted Abresch, Alina Nicorici, Gary L Elfring, Leone Atkinson, Allen Reha, Samit Hirawat, Langdon L Miller. Muscle Nerve 2010
238
5

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
5

Function and genetics of dystrophin and dystrophin-related proteins in muscle.
Derek J Blake, Andrew Weir, Sarah E Newey, Kay E Davies. Physiol Rev 2002
785
5

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
Jeffrey S Chamberlain, Joseph Metzger, Morayma Reyes, DeWayne Townsend, John A Faulkner. FASEB J 2007
226
5

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.
Luca Bello, Lauren P Morgenroth, Heather Gordish-Dressman, Eric P Hoffman, Craig M McDonald, Sebahattin Cirak. Neurology 2016
61
8

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
Robert C Griggs, J Phillip Miller, Cheryl R Greenberg, Darcy L Fehlings, Alan Pestronk, Jerry R Mendell, Richard T Moxley, Wendy King, John T Kissel, Valerie Cwik,[...]. Neurology 2016
80
6

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, Lucy Feng, Silvia Torelli, Karen Anthony, Stephen Abbs, Maria Elena Garralda, John Bourke, Dominic J Wells,[...]. Lancet 2011
601
5


Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
Annemieke Aartsma-Rus, Ivo Fokkema, Jan Verschuuren, Ieke Ginjaar, Judith van Deutekom, Gert-Jan van Ommen, Johan T den Dunnen. Hum Mutat 2009
348
5

Eteplirsen for the treatment of Duchenne muscular dystrophy.
Jerry R Mendell, Louise R Rodino-Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda P Lowes, Lindsay Alfano, Ann Maria Gomez, Sarah Lewis, Janaiah Kota,[...]. Ann Neurol 2013
434
5


Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.
Kevin M Flanigan, Diane M Dunn, Andrew von Niederhausern, Payam Soltanzadeh, Eduard Gappmaier, Michael T Howard, Jacinda B Sampson, Jerry R Mendell, Cheryl Wall, Wendy M King,[...]. Hum Mutat 2009
189
5

Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation.
Michelle Eagle, Simon V Baudouin, Colin Chandler, David R Giddings, Robert Bullock, Kate Bushby. Neuromuscul Disord 2002
518
5



All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy.
Gernot Schram, Anne Fournier, Hugues Leduc, Nagib Dahdah, Johanne Therien, Michel Vanasse, Paul Khairy. J Am Coll Cardiol 2013
116
5

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.
C M McDonald, R T Abresch, G T Carter, W M Fowler, E R Johnson, D D Kilmer, B J Sigford. Am J Phys Med Rehabil 1995
283
4

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
Elena Mazzone, Diego Martinelli, Angela Berardinelli, Sonia Messina, Adele D'Amico, Gessica Vasco, Marion Main, Luca Doglio, Luisa Politano, Filippo Cavallaro,[...]. Neuromuscul Disord 2010
124
4

Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.
Marika Pane, Elena Stacy Mazzone, Serena Sivo, Maria Pia Sormani, Sonia Messina, Adele D'Amico, Adelina Carlesi, Gianluca Vita, Lavinia Fanelli, Angela Berardinelli,[...]. PLoS One 2014
78
5

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
Elena Stacy Mazzone, Marika Pane, Maria Pia Sormani, Roberta Scalise, Angela Berardinelli, Sonia Messina, Yvan Torrente, Adele D'Amico, Luca Doglio, Emanuela Viggiano,[...]. PLoS One 2013
73
5

Clinical trial in Duchenne dystrophy. I. The design of the protocol.
M H Brooke, R C Griggs, J R Mendell, G M Fenichel, J B Shumate, R J Pellegrino. Muscle Nerve 1981
413
4

Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids.
Nathalie Goemans, Marleen van den Hauwe, Rosamund Wilson, Annelies van Impe, Katrijn Klingels, Gunnar Buyse. Neuromuscul Disord 2013
45
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.